Financial_NN
Statements_NOMZ
87_CD
ACCOUNTING_GER
POLICIES_NN
BASIS_NN
OF_PIN
ACCOUNTING_GER
basis_NN
over_IN
their_TPP3
useful_JJ
economic_JJ
lives_NN
from_PIN
Payments_NOMZ
to_TO
defined_VBN
contribution_NOMZ
schemes_NN
The_DT
consolidated_JJ
financial_JJ
statements_NOMZ
have_VPRT
product_NN
launch_NN
._.
Payments_NOMZ
to_PIN
in-licence_NN
are_VPRT [PASS]
recognized_VBN [PRIV]
in_PIN
the_DT
income_NN
statement_NOMZ
as_IN
been_VBN [PASS]
prepared_VBN
under_IN
the_DT
historical_JJ
cost_NN
products_NN
and_PHC
compounds_NN
from_PIN
external_JJ
third_JJ
they_TPP3
fall_VPRT
due_JJ
._.
convention_NOMZ
,_,
modified_VBN
to_TO
include_VB
revaluation_NOMZ
parties_NN
,_,
generally_RB
taking_VBG
the_DT
form_NN
of_PIN
up-front_JJ
to_PIN
fair_JJ
value_NN
of_PIN
certain_JJ
financial_JJ
instruments_NOMZ
payments_NOMZ
and_PHC
milestones_NN
,_,
are_VPRT [PASS]
capitalized_VBN
and_CC
Taxation_NOMZ
as_IN
described_VBN
below_PLACE
,_,
in_PIN
accordance_NN
with_PIN
the_DT
amortised_JJ
,_,
generally_RB
on_PIN
a_DT
straight_JJ
line_NN
basis_NN
,_,
The_DT
charge_NN
for_PIN
taxation_NOMZ
is_VPRT [PASS]
based_VBN
on_PIN
the_DT
profits_NN
Companies_NN
Act_NN
1985_CD
and_CC
International_NN
over_IN
their_TPP3
economic_JJ
lives_NN
from_PIN
launch_NN
._.
Under_IN
for_PIN
the_DT
year_NN
and_CC
takes_VPRT
into_PIN
account_NN
taxation_NOMZ
Financial_NN
Reporting_GER
Standards_NN
IFRSs_NN
as_IN
this_DEMO
policy_NN
,_,
it_PIT
is_VPRT [BEMA]
not_XX0
possible_PRED
to_TO
determine_VB [SUAV] [PRIV]
deferred_VBN
because_CAUS
of_PIN
temporary_JJ
differences_NN
adopted_VBN [WZPAST]
by_PIN
the_DT
European_NN
Union_NN
in_PIN
response_NN
precise_JJ
economic_JJ
lives_NN
for_PIN
individual_JJ
classes_NN
between_PIN
the_DT
treatment_NOMZ
of_PIN
certain_JJ
items_NN
for_PIN
to_PIN
the_DT
IAS_NN
regulation_NOMZ
EC_NN
1606_CD
2002_CD
._.
of_PIN
intangible_JJ
._.
However_CONJ
,_,
lives_VPRT
range_NN
from_PIN
three_CD
taxation_NOMZ
and_CC
for_PIN
accounting_GER
purposes_NN
._.
Full_JJ
years_NN
to_PIN
twenty_CD
years_NN
._.
Intangible_JJ
assets_NN
relating_VBG [WZPRES]
provision_NN
is_VPRT [PASS]
made_VBN
for_PIN
the_DT
tax_NN
effects_NN
of_PIN
these_DEMO
Where_RB
there_EX
are_VPRT
significant_JJ
differences_NN
to_TO
to_PIN
products_NN
in_PIN
development_NOMZ
both_DT
internally_RB
differences_NN
._.
Deferred_JJ
tax_NN
assets_NN
are_VPRT [PASS]
recognized_VBN [PRIV]
US_FPP1
GAAP_NN
these_DEMP
have_VPRT [PEAS]
been_VBN [PASS]
described_VBN
in_PIN
the_DT
generated_VBN
and_CC
externally_RB
acquired_VBN
are_VPRT [BEMA]
subject_PRED
to_PIN
the_DT
extent_NN
that_TOBJ
it_PIT
is_VPRT [BEMA]
probable_PRED
that_THAC
taxable_JJ
US_FPP1
GAAP_NN
section_NOMZ
on_PIN
pages_NN
130_CD
to_PIN
136_CD
._.
to_PIN
impairment_NOMZ
testing_GER
at_PIN
each_QUAN
balance_NN
sheet_NN
profit_NN
will_PRMD
be_VB [BEMA]
available_PRED
against_PIN
which_WDT [PIRE]
the_DT
asset_NN
date_NN
._.
All_QUAN
intangible_JJ
assets_NN
are_VPRT [PASS]
tested_VBN
for_PIN
can_POMD
be_VB [PASS]
utilised_VBN
._.
This_DEMP
requires_VPRT [SUAV]
judgements_NOMZ
to_PIN
In_PIN
preparing_VBG
their_TPP3
individual_JJ
financial_JJ
statements_NOMZ
,_,
impairment_NOMZ
when_RB
there_EX
are_VPRT
indications_NOMZ
that_TSUB
be_VB [PASS]
made_VBN
in_PIN
respect_NN
of_PIN
the_DT
forecast_NN
of_PIN
future_JJ
the_DT
accounting_GER
policies_NN
of_PIN
some_QUAN
overseas_PLACE
the_DT
carrying_VBG
value_NN
may_POMD
not_XX0
be_VB [BEMA]
recoverable_PRED
._.
subsidiaries_NN
and_CC
associated_VBN
undertakings_GER
Any_QUAN
impairment_NOMZ
losses_NN
are_VPRT [PASS]
recognized_VBN [PRIV]
do_VPRT
not_XX0
conform_VB
with_PIN
IFRSs_NN
._.
Therefore_CONJ
,_,
where_RB
immediately_TIME
in_PIN
the_DT
income_NN
statement_NOMZ
._.
No_SYNE
deferred_JJ
tax_NN
asset_NN
or_CC
liability_NOMZ
is_VPRT [PASS]
recognized_VBN [PRIV]
appropriate_JJ
,_,
adjustments_NOMZ
are_VPRT [PASS]
made_VBN
in_PIN
order_NN
in_PIN
respect_NN
of_PIN
temporary_JJ
differences_NN
associated_VBN
to_TO
present_VB
the_DT
Group_NN
Financial_NN
Statements_NOMZ
Business_NOMZ
combinations_NOMZ
and_PHC
goodwill_NN
with_PIN
investments_NOMZ
in_PIN
subsidiaries_NN
,_,
branches_NN
on_PIN
a_DT
consistent_JJ
basis_NN
._.
On_PIN
the_DT
acquisition_NOMZ
of_PIN
a_DT
business_NOMZ
,_,
fair_JJ
values_NN
are_VPRT
and_CC
joint_JJ
ventures_NN
where_RB
the_DT
Group_NN
is_VPRT [BEMA]
able_PRED
attributed_VBN
to_PIN
the_DT
identifiable_JJ
assets_NN
,_,
liabilities_NOMZ
to_TO
control_VB
the_DT
timing_NN
of_PIN
reversal_NN
of_PIN
the_DT
AstraZenecas_NN
management_NOMZ
considers_VPRT [PRIV]
the_DT
and_CC
contingent_JJ
liabilities_NOMZ
acquired_VBN
._.
Goodwill_NN
temporary_JJ
differences_NN
and_CC
it_PIT
is_VPRT [BEMA]
probable_PRED
that_THAC
following_VBG
to_TO
be_VB [BEMA]
the_DT
most_EMPH
important_JJ
accounting_GER
arises_VPRT
where_RB
the_DT
fair_JJ
value_NN
of_PIN
the_DT
consideration_NOMZ
the_DT
temporary_JJ
differences_NN
will_PRMD
not_XX0
reverse_VB
in_PIN
policies_NN
in_PIN
the_DT
context_NN
of_PIN
the_DT
Groups_NN
operations_NOMZ
._.
given_VBN [PASTP]
for_PIN
a_DT
business_NOMZ
exceeds_VPRT
the_DT
fair_JJ
value_NN
the_DT
foreseeable_JJ
future_NN
._.
of_PIN
such_JJ
assets_NN
,_,
liabilities_NOMZ
and_CC
contingent_JJ
In_PIN
applying_VBG
these_DEMO
accounting_GER
policies_NN
liabilities_NOMZ
acquired_VBN
._.
Accruals_NN
for_PIN
tax_NN
contingencies_NN
require_VPRT [SUAV] [THATD]
management_NOMZ
makes_VPRT
certain_JJ
judgements_NOMZ
and_PHC
management_NOMZ
to_TO
make_VB
judgements_NOMZ
and_PHC
estimations_NOMZ
._.
Judgements_NOMZ
include_VPRT
classification_NOMZ
Goodwill_NN
arising_VBG [WZPRES]
on_PIN
acquisitions_NOMZ
is_VPRT [PASS]
capitalized_VBN
estimates_NN
of_PIN
ultimate_JJ
exposures_NN
in_PIN
relation_NOMZ
to_PIN
of_PIN
transactions_NOMZ
between_PIN
the_DT
income_NN
statement_NOMZ
and_PHC
subject_NN
to_PIN
an_DT
impairment_NOMZ
review_NN
,_,
both_DT
tax_NN
audit_NN
issues_NN
._.
Tax_NN
benefits_NN
are_VPRT [PASS]
not_XX0
recognized_VBN [PRIV]
and_CC
balance_NN
sheet_NN
,_,
whilst_OSUB
estimations_NOMZ
focus_VB
on_PIN
annually_RB
and_ANDC
when_RB
there_EX
is_VPRT
an_DT
indication_NOMZ
that_DEMO
unless_COND
the_DT
tax_NN
positions_NOMZ
will_PRMD [SPAU]
probably_RB
be_VB
areas_NN
such_JJ
as_IN
carrying_VBG
values_NN
and_CC
estimated_VBN [PRIV]
lives_NN
._.
the_DT
carrying_VBG
value_NN
may_POMD
not_XX0
be_VB [BEMA]
recoverable_PRED
._.
Once_TIME
considered_VBN [PRIV]
to_TO
be_VB [BEMA]
probable_PRED
,_,
Prior_RB
to_PIN
1_CD
January_NN
2003_CD
,_,
goodwill_NN
was_VBD
management_NOMZ
reviews_NN
each_QUAN
material_NN
tax_NN
benefit_NN
The_DT
accounting_GER
policy_NN
descriptions_NOMZ
set_VBN [WZPAST]
out_PIN
the_DT
amortised_VBN
over_IN
its_PIT
estimated_VBN [PRIV]
useful_JJ
life_NN
:_:
such_JJ
to_TO
assess_VB
whether_IN
a_DT
provision_NN
should_NEMD
be_VB
areas_NN
where_RB
judgement_NOMZ
needs_VPRT
exercising_VBG
,_,
the_DT
amortisation_NOMZ
ceased_VBD
on_PIN
31_CD
December_NN
2002_CD
._.
taken_VBN [PASTP]
against_PIN
full_JJ
recognition_NOMZ
of_PIN
that_DEMO
benefit_NN
most_EMPH
significant_JJ
of_PIN
which_WDT [PIRE]
are_VPRT [BEMA]
the_DT
classification_NOMZ
of_PIN
on_PIN
the_DT
basis_NN
of_PIN
potential_JJ
settlement_NOMZ
through_PIN
financial_JJ
instruments_NOMZ
and_CC
the_DT
transition_NOMZ
elections_NOMZ
The_DT
Groups_NN
policy_NN
up_IN
to_TO
and_CC
including_VBG
1997_CD
negotiation_NOMZ
and_CC
or_CC
litigation_NOMZ
._.
Any_QUAN
recorded_VBN
made_VBN
under_IN
IFRS_NN
1_CD
First-time_JJ
Adoption_NOMZ
of_PIN
was_VBD
to_TO
eliminate_VB
goodwill_NN
arising_VBG [WZPRES]
upon_PIN
exposure_NN
to_PIN
interest_NN
on_PIN
tax_NN
liabilities_NOMZ
is_VPRT
International_NN
Financial_NN
Reporting_GER
Standards_NN
._.
Under_IN
IFRS_NN
1_CD
provided_VBN
for_PIN
in_PIN
the_DT
tax_NN
charge_NN
._.
First-time_JJ
Adoption_NOMZ
of_PIN
International_NN
Financial_NN
Revenue_NN
Reporting_GER
Standards_NN
and_PHC
IFRS_NN
3_NN
Business_NOMZ
Share-based_JJ
payments_NOMZ
Sales_NN
exclude_VPRT
inter-company_JJ
sales_NN
and_PHC
valueCombinations_NOMZ
,_,
such_JJ
goodwill_NN
will_PRMD
remain_VB
The_DT
fair_JJ
value_NN
of_PIN
employee_NN
share_NN
option_NOMZ
plans_VPRT
added_JJ
taxes_NN
and_CC
represent_VPRT
net_JJ
invoice_NN
value_NN
eliminated_VBN [WZPAST]
against_PIN
reserves_NN
._.
is_VPRT [SPAU] [PASS]
generally_RB
calculated_VBN [PRIV]
using_VBG
the_DT
Black-Scholes_NN
less_JJ
estimated_JJ
rebates_NN
,_,
returns_NN
and_PHC
settlement_NOMZ
model_NN
._.
In_PIN
accordance_NN
with_PIN
IFRS_NN
2_CD
Share-based_JJ
discounts_NN
._.
Sales_NN
are_VPRT [PASS]
recognized_VBN [PRIV]
when_RB [WHCL]
the_DT
Employee_NN
benefits_NN
Payments_NOMZ
,_,
the_DT
resulting_VBG
cost_NN
is_VPRT [PASS]
recognized_VBN [PRIV]
in_PIN
significant_JJ
risks_NN
and_PHC
rewards_NN
of_PIN
ownership_NN
have_VPRT
The_DT
Group_NN
accounts_NN
for_PIN
pensions_NN
and_CC
other_JJ
the_DT
income_NN
statement_NOMZ
over_IN
the_DT
vesting_JJ
period_NN
been_VBN [PASS]
transferred_VBN
to_PIN
a_DT
third_JJ
party_NN
._.
No_SYNE
revenue_NN
employee_NN
benefits_NN
principally_RB
healthcare_NN
under_IN
of_PIN
the_DT
options_NOMZ
,_,
being_VBG [PRESP] [BEMA]
the_DT
period_NN
in_PIN
which_WDT [PIRE]
the_DT
is_VPRT [PASS]
recognized_VBN [PRIV]
when_RB [WHCL]
there_EX
are_VPRT
significant_JJ
IAS_NN
19_CD
Employee_NN
Benefits_NN
._.
In_PIN
respect_NN
of_PIN
services_NN
are_VPRT [PASS]
received_VBN
._.
The_DT
value_NN
of_PIN
the_DT
charge_NN
uncertainties_NN
regarding_VBG [WZPRES]
the_DT
consideration_NOMZ
defined_VBN
benefit_NN
plans_NN
,_,
obligations_NOMZ
are_VPRT [PASS]
measured_VBN
is_VPRT [PASS]
adjusted_VBN
to_TO
reflect_VB [PRIV]
expected_VBN [PRIV]
and_CC
actual_JJ
to_TO
be_VB [PASS]
received_VBN
or_CC
the_DT
costs_NN
associated_VBN [WZPAST]
with_PIN
at_PIN
discounted_JJ
present_JJ
value_NN
whilst_OSUB
plan_NN
assets_NN
levels_NN
of_PIN
options_NOMZ
vesting_GER
,_,
except_PIN
where_RB
the_DT
the_DT
transaction_NOMZ
._.
are_VPRT [PASS]
measured_VBN
at_PIN
fair_JJ
value_NN
._.
The_DT
operating_GER
and_PHC
failure_NN
to_PIN
vest_NN
is_VPRT
as_CONJ
a_NULL
result_NULL
of_PIN
not_XX0
meeting_VBG
financing_GER
costs_NN
of_PIN
such_JJ
plans_NN
are_VPRT [PASS]
recognized_VBN [PRIV]
a_DT
market_NN
condition_NOMZ
._.
All_QUAN
plans_NN
are_VPRT [PASS]
classified_VBN
Research_NN
and_PHC
development_NOMZ
separately_RB
in_PIN
the_DT
income_NN
statement_NOMZ
:_:
service_NN
as_IN
equity_NOMZ
settled_VBN
._.
Research_NN
expenditure_NN
is_VPRT [PASS]
recognized_VBN [PRIV]
in_PIN
costs_NN
are_VPRT [PASS]
spread_VBN
systematically_RB
over_IN
the_DT
lives_NN
the_DT
income_NN
statement_NOMZ
in_PIN
the_DT
year_NN
in_PIN
which_WDT [PIRE]
of_PIN
employees_NN
and_PHC
financing_GER
costs_NN
are_VPRT
Property_NN
,_,
plant_NN
and_PHC
equipment_NOMZ
it_PIT
is_VPRT [PASS]
incurred_VBN
._.
recognized_VBN [PRIV] [PASTP]
in_PIN
full_JJ
in_PIN
the_DT
periods_NN
in_PIN
which_WDT [PIRE]
they_TPP3
The_DT
Groups_NN
policy_NN
is_VPRT
to_TO
write_VB [PUBV]
off_PIN
the_DT
difference_NN
arise_VB
._.
Actuarial_JJ
gains_NN
and_PHC
losses_NN
are_VPRT [PASS]
recognized_VBN [PRIV]
between_PIN
the_DT
cost_NN
of_PIN
each_QUAN
item_NN
of_PIN
property_NN
,_,
Internal_NN
development_NOMZ
expenditure_NN
is_VPRT [PASS]
recognized_VBN [PRIV]
immediately_TIME
in_PIN
the_DT
statement_NOMZ
of_PIN
recognized_VBN [PRIV]
plant_NN
and_PHC
equipment_NOMZ
and_CC
its_PIT
residual_JJ
value_NN
in_PIN
the_DT
income_NN
statement_NOMZ
in_PIN
the_DT
year_NN
in_PIN
which_WDT [PIRE]
income_NN
and_PHC
expense_NN
._.
systematically_RB
over_IN
its_PIT
estimated_VBN [PRIV]
useful_JJ
life_NN
._.
it_PIT
is_VPRT [PASS]
incurred_VBN
unless_COND
it_PIT
meets_VPRT
the_DT
recognition_NOMZ
Assets_NN
under_IN
construction_NOMZ
are_VPRT [PASS]
not_XX0
depreciated_VBN
._.
criteria_NN
of_PIN
IAS_NN
38_CD
Intangible_NN
Assets_NN
._.
Regulatory_NN
Where_RB
the_DT
calculation_NOMZ
results_NN
in_PIN
a_DT
benefit_NN
to_PIN
the_DT
and_CC
other_JJ
uncertainties_NN
generally_RB
mean_VPRT [PRIV]
that_THVC
Group_NN
,_,
the_DT
recognized_VBN [PRIV] [THATD]
asset_NN
is_VPRT [PASS]
limited_VBN
to_PIN
the_DT
Reviews_NN
are_VPRT [PASS]
made_VBN
annually_RB
of_PIN
the_DT
estimated_VBN [PRIV] [THATD]
such_JJ
criteria_NN
are_VPRT [PASS]
not_XX0
met_VBN
._.
Where_RB
,_,
however_CONJ
,_,
the_DT
present_JJ
value_NN
of_PIN
any_QUAN
future_JJ
refunds_NN
from_PIN
the_DT
remaining_VBG
lives_NN
and_CC
residual_JJ
values_NN
of_PIN
individual_JJ
recognition_NOMZ
criteria_NN
are_VPRT [PASS]
met_VBN
,_,
intangible_JJ
assets_NN
plan_VPRT
or_CC
reductions_NOMZ
in_PIN
future_JJ
contributions_NOMZ
to_PIN
the_DT
productive_JJ
assets_NN
,_,
taking_VBG
account_NN
of_PIN
are_VPRT [PASS]
capitalized_VBN
and_PHC
amortised_VBN
on_PIN
a_DT
straight-line_JJ
plan_NN
._.
commercial_JJ
and_PHC
technological_JJ
obsolescence_NN
AstraZeneca_NN
Annual_JJ
Report_NN
and_CC
88_CD
Form_NN
20-F_JJ
Information_NOMZ
2005_CD
ACCOUNTING_GER
POLICIES_NN
CONTINUED_VBD
as_RB
well_RB
as_IN
normal_JJ
wear_NN
and_CC
tear_VB
._.
Under_IN
this_DEMO
Inventories_NN
For_PIN
assets_NN
and_CC
long_JJ
term_NN
loans_NN
classified_VBN
policy_NN
it_PIT
becomes_VPRT
impractical_JJ
to_TO
calculate_VB [PRIV] [THATD]
Inventories_NN
are_VPRT [PASS]
stated_VBN [PUBV]
at_PIN
the_DT
lower_JJ
of_PIN
cost_NN
or_CC
as_IN
fair_JJ
value_NN
through_PIN
profit_NN
or_CC
loss_NN
and_PHC
assets_NN
average_JJ
asset_NN
lives_VPRT
exactly_RB
._.
However_CONJ
,_,
the_DT
total_JJ
net_JJ
realisable_JJ
value_NN
._.
The_DT
first_JJ
in_PIN [STPR]
,_,
first_RB
out_PIN
or_CC
held_VBN [PRIV]
for_PIN
trading_GER
,_,
all_QUAN
changes_NN
in_PIN
fair_JJ
value_NN
are_VPRT
lives_NN
range_VPRT
from_PIN
approximately_RB
thirteen_VBN
to_TO
fifty_VB
an_DT
average_JJ
method_NN
of_PIN
valuation_NOMZ
is_VPRT [PASS]
used_VBN
._.
For_PIN
recognized_VBN [PRIV]
in_PIN
the_DT
income_NN
statement_NOMZ
._.
years_NN
for_PIN
buildings_GER
,_,
and_ANDC
three_CD
to_PIN
fifteen_CD
years_NN
finished_VBN
goods_NN
and_PHC
work_NN
in_PIN
progress_NN
,_,
cost_NN
for_PIN
plant_NN
and_PHC
equipment_NOMZ
._.
All_QUAN
items_NN
of_PIN
property_NN
,_,
includes_VPRT
directly_RB
attributable_JJ
costs_NN
and_CC
certain_JJ
Contingent_JJ
liabilities_NOMZ
plant_NN
and_PHC
equipment_NOMZ
are_VPRT [PASS]
tested_VBN
for_PIN
impairment_NOMZ
overhead_NN
expenses_NN
including_VBG [WZPRES]
depreciation_NOMZ
._.
Through_PIN
the_DT
normal_JJ
course_NN
of_PIN
business_NOMZ
,_,
when_RB
there_EX
are_VPRT
indications_NOMZ
that_TOBJ
the_DT
carrying_VBG
Selling_VBG
expenses_NN
and_CC
certain_JJ
other_JJ
overhead_JJ
AstraZeneca_NN
is_VPRT [PASS]
involved_VBN
in_PIN
legal_JJ
disputes_NN
,_,
the_DT
value_NN
may_POMD
not_XX0
be_VB [BEMA]
recoverable_PRED
._.
Any_QUAN
impairment_NOMZ
expenses_NN
principally_RB
central_JJ
administration_NOMZ
settlement_NOMZ
of_PIN
which_WDT [PIRE]
may_POMD
involve_VB
cost_NN
to_PIN
the_DT
losses_NN
are_VPRT [PASS]
written_VBN [PUBV]
off_PIN
immediately_TIME
to_PIN
income_NN
._.
Net_JJ
realisable_JJ
value_NN
is_VPRT
Group_NN
._.
Provision_NN
is_VPRT [PASS]
made_VBN
where_RB
an_DT
adverse_JJ
determined_VBN [SUAV] [PRIV]
as_IN
estimated_VBN [PRIV]
selling_GER
price_NN
less_RB
all_QUAN
outcome_NN
is_VPRT [BEMA]
probable_PRED
and_CC
associated_VBN
costs_NN
Borrowing_VBG [WZPRES]
costs_NN
estimated_VBN [PRIV]
costs_NN
of_PIN
completion_NOMZ
and_PHC
costs_NN
to_TO
be_VB
can_POMD
be_VB [PASS]
estimated_VBN [PRIV]
reliably_RB
._.
Borrowing_GER
costs_NN
are_VPRT [PASS]
recognized_VBN [PRIV]
in_PIN
the_DT
income_NN
incurred_VBN [WZPAST]
in_PIN
marketing_GER
,_,
selling_VBG
and_CC
distribution_NOMZ
._.
AstraZeneca_NN
is_VPRT [PASS]
exposed_VBN
to_PIN
environmental_JJ
Write_JJ
downs_NN
of_PIN
inventory_NN
occur_VPRT
regularly_RB
in_PIN
the_DT
liabilities_NOMZ
relating_VBG [WZPRES]
to_PIN
its_PIT
past_JJ
operations_NOMZ
,_,
Leases_VPRT
general_JJ
course_NN
of_PIN
business_NOMZ
and_CC
are_VPRT [PASS]
included_VBN
principally_RB
in_PIN
respect_NN
of_PIN
soil_NN
and_PHC
groundwater_NN
Assets_NN
held_VBN [PRIV]
under_IN
finance_NN
leases_NN
are_VPRT [PASS]
capitalized_VBN
in_PIN
cost_NN
of_PIN
sales_NN
in_PIN
the_DT
income_NN
statement_NOMZ
._.
Provisions_NN
for_PIN
these_DEMO
costs_NN
and_CC
included_VBN
in_PIN
tangible_JJ
fixed_JJ
assets_NN
at_PIN
fair_JJ
are_VPRT [PASS]
made_VBN
when_RB
there_EX
is_VPRT
a_DT
present_JJ
obligation_NOMZ
value_NN
._.
Each_QUAN
asset_NN
is_VPRT [PASS]
depreciated_VBN
over_IN
the_DT
Financial_NN
instruments_NOMZ
and_ANDC
where_RB
it_PIT
is_VPRT [BEMA]
probable_PRED
that_THAC
expenditure_NN
shorter_JJ
of_PIN
the_DT
lease_NN
term_NN
or_CC
its_PIT
useful_JJ
life_NN
._.
Financial_NN
instruments_NOMZ
are_VPRT [PASS]
recorded_VBN
initially_TIME
at_PIN
on_PIN
remedial_JJ
work_NN
will_PRMD
be_VB [PASS]
required_VBN [SUAV]
and_CC
that_THVC
The_DT
obligations_NOMZ
related_VBN
to_TO
finance_VB
leases_NN
,_,
net_JJ
fair_JJ
value_NN
._.
Subsequent_JJ
measurement_NOMZ
depends_VPRT
a_DT
reliable_JJ
estimate_NN
can_POMD
be_VB [PASS]
made_VBN
of_PIN
the_DT
cost_NN
._.
of_PIN
finance_NN
charges_NN
in_PIN
respect_NN
of_PIN
future_JJ
periods_NN
,_,
on_PIN
the_DT
designation_NOMZ
of_PIN
the_DT
instrument_NOMZ
,_,
as_IN
follows_VPRT
:_:
Provisions_NN
are_VPRT [PASS]
discounted_VBN
where_RB
the_DT
effect_NN
are_VPRT [PASS]
included_VBN
,_,
as_IN
appropriate_JJ
,_,
under_IN
current_JJ
is_VPRT
material_NN
._.
Investments_NOMZ
other_JJ
than_PIN
interests_NN
in_PIN
joint_JJ
ventures_NN
,_,
associates_NN
and_CC
fixed_VBN
deposits_NN
Foreign_JJ
currencies_NN
The_DT
interest_NN
element_NOMZ
of_PIN
the_DT
rental_JJ
obligation_NOMZ
and_CC
short_JJ
term_NN
investments_NOMZ
other_JJ
than_PIN
Income_NN
statement_NOMZ
items_NN
in_PIN
foreign_JJ
currencies_NN
is_VPRT [PASS]
allocated_VBN
to_PIN
accounting_GER
periods_NN
during_PIN
the_DT
fixed_VBN
deposits_NN
are_VPRT [SPAU] [PASS]
normally_RB
designated_VBN
are_VPRT [PASS]
translated_VBN
into_PIN
US_FPP1
dollars_NN
at_PIN
average_JJ
lease_NN
term_NN
to_TO
reflect_VB [PRIV]
a_DT
constant_JJ
rate_NN
of_PIN
interest_NN
as_IN
available_JJ
for_PIN
sale_NN
._.
Where_RB
the_DT
exposure_NN
exchange_NN
rates_NN
,_,
which_WDT [SERE]
approximate_JJ
to_PIN
actual_JJ
on_PIN
the_DT
remaining_VBG
balance_NN
of_PIN
the_DT
obligation_NOMZ
for_PIN
to_PIN
a_DT
change_NN
in_PIN
fair_JJ
value_NN
of_PIN
such_PDT
an_DT
asset_NN
rates_NN
,_,
for_PIN
the_DT
relevant_JJ
accounting_GER
periods_NN
._.
is_VPRT [SPAU] [BYPA]
substantially_RB
offset_VBN
by_PIN
the_DT
exposure_NN
Assets_NN
and_PHC
liabilities_NOMZ
are_VPRT [PASS]
translated_VBN
at_PIN
exchange_NN
to_PIN
a_DT
change_NN
in_PIN
the_DT
fair_JJ
value_NN
of_PIN
derivatives_NN
,_,
rates_NN
prevailing_VBG [WZPRES]
at_PIN
the_DT
date_NN
of_PIN
the_DT
Group_NN
Rentals_NN
under_IN
operating_VBG
leases_NN
are_VPRT [PASS]
charged_VBN
to_PIN
the_DT
asset_NN
is_VPRT [SPAU] [PASS]
generally_RB
classified_VBN
as_IN
fair_JJ
value_NN
balance_NN
sheet_NN
._.
the_DT
income_NN
statement_NOMZ
on_PIN
a_DT
straight-line_JJ
basis_NN
._.
Exchange_NN
gains_NN
and_PHC
losses_NN
on_PIN
short_JJ
term_NN
Subsidiaries_NN
,_,
associates_NN
and_CC
joint_JJ
ventures_NN
Fixed_VBN
deposits_NN
,_,
comprising_VBG [PRESP]
principally_RB
foreign_JJ
currency_NN
borrowings_GER
and_PHC
deposits_NN
are_VPRT [BEMA]
A_DT
subsidiary_NN
is_VPRT [BEMA]
an_DT
entity_NOMZ
controlled_VBN
,_,
directly_RB
or_CC
funds_NN
held_VBN [PRIV] [WZPAST]
with_PIN
banks_NN
and_CC
other_JJ
financial_JJ
included_VBN
within_PIN
finance_NN
income_NN
and_PHC
finance_NN
indirectly_RB
,_,
by_PIN
AstraZeneca_NN
._.
Control_NN
is_VPRT [PASS]
regarded_VBN
institutions_NOMZ
,_,
classified_VBN
as_IN
loans_NN
and_PHC
expense_NN
._.
Exchange_NN
differences_NN
on_PIN
all_QUAN
other_JJ
as_IN
the_DT
power_NN
to_TO
govern_VB
the_DT
financial_JJ
and_CC
receivables_NN
,_,
and_ANDC
short_JJ
term_NN
borrowings_GER
transactions_NOMZ
,_,
except_PIN
relevant_JJ
foreign_JJ
currency_NN
operating_VBG [WZPRES]
policies_NN
of_PIN
the_DT
entity_NOMZ
so_RB
as_IN
to_TO
obtain_VB
and_CC
overdrafts_NN
,_,
classified_VBN
as_IN
other_JJ
liabilities_NOMZ
,_,
loans_NN
,_,
are_VPRT [PASS]
taken_VBN
to_TO
operating_VBG
profit_NN
._.
are_VPRT [PASS]
held_VBN [PRIV]
at_PIN
amortised_JJ
cost_NN
._.
In_PIN
the_DT
consolidated_JJ
financial_JJ
statements_NOMZ
An_DT
associate_NN
is_VPRT [BEMA]
an_DT
undertaking_GER
,_,
not_XX0
being_VBG
Derivatives_NN
,_,
comprising_VBG
interest_NN
rate_NN
swaps_NN
,_,
exchange_NN
differences_NN
arising_VBG [WZPRES]
on_PIN
consolidation_NOMZ
a_DT
subsidiary_NN
or_CC
joint_JJ
venture_NN
,_,
over_IN
whose_WPS
foreign_JJ
exchange_NN
contracts_NN
and_PHC
options_NOMZ
of_PIN
the_DT
net_JJ
investments_NOMZ
in_PIN
subsidiaries_NN
,_,
joint_JJ
commercial_JJ
and_PHC
financial_JJ
policy_NN
decisions_NN
and_CC
embedded_VBN
derivatives_NN
,_,
are_VPRT [BEMA]
classified_JJ
ventures_NN
and_PHC
associates_NN
together_RB
with_PIN
those_DEMO
AstraZeneca_NN
has_VPRT
significant_JJ
influence_NN
._.
on_PIN
relevant_JJ
foreign_JJ
currency_NN
loans_NN
are_VPRT [PASS]
taken_VBN
directly_RB
to_PIN
equity_NOMZ
via_PIN
the_DT
statement_NOMZ
of_PIN
recognized_VBN [PRIV] [THATD]
A_DT
joint_JJ
venture_NN
is_VPRT [BEMA]
an_DT
entity_NOMZ
which_WDT [WHSUB]
is_VPRT [BEMA]
jointly_RB
Long_JJ
term_NN
loans_NN
,_,
where_RB
the_DT
change_NN
in_PIN
fair_JJ
income_NN
and_PHC
expense_NN
._.
controlled_VBN [PASTP]
by_PIN
AstraZeneca_NN
and_CC
one_CD
or_CC
more_EMPH
value_NN
is_VPRT [SPAU] [BYPA]
substantially_RB
offset_VBN
by_PIN
the_DT
exposure_NN
other_JJ
venturers_NN
under_IN
a_DT
contractual_JJ
arrangement_NOMZ
._.
to_PIN
a_DT
change_NN
in_PIN
the_DT
fair_JJ
value_NN
of_PIN
derivatives_NN
,_,
IFRS_NN
transitional_JJ
arrangements_NOMZ
are_VPRT [PASS]
classified_VBN
as_IN
fair_JJ
value_NN
through_PIN
profit_NN
or_CC
and_CC
early_TIME
adoption_NOMZ
AstraZenecas_NN
share_NN
of_PIN
the_DT
profits_NN
less_RB
losses_NN
loss_NN
when_RB
certain_JJ
criteria_NN
are_VPRT [PASS]
met_VBN
._.
When_RB
preparing_VBG
the_DT
consolidated_JJ
balance_NN
of_PIN
joint_JJ
ventures_NN
and_PHC
associates_NN
is_VPRT [PASS]
included_VBN
in_PIN
sheet_NN
under_IN
IFRS_NN
at_PIN
1_CD
January_NN
2003_CD
,_,
the_DT
date_NN
the_DT
Group_NN
income_NN
statement_NOMZ
on_PIN
the_DT
equity_NOMZ
Changes_NN
in_PIN
the_DT
fair_JJ
value_NN
of_PIN
financial_JJ
of_PIN
transition_NOMZ
,_,
the_DT
following_VBG
optional_JJ
exemptions_NOMZ
accounting_VBG [WZPRES]
basis_NN
._.
The_DT
holding_GER
value_NN
of_PIN
instruments_NOMZ
are_VPRT [PASS]
dealt_VBN
with_PIN
as_IN
follows_VPRT
:_:
from_PIN
full_JJ
retrospective_JJ
application_NOMZ
of_PIN
IFRS_NN
associates_NN
and_CC
joint_JJ
ventures_NN
in_PIN
the_DT
Group_NN
accounting_GER
policies_NN
have_VPRT [PEAS]
been_VBN [PASS]
adopted_VBN
:_:
balance_NN
sheet_NN
is_VPRT [BYPA]
calculated_VBN [PRIV]
by_PIN
reference_NN
to_PIN
For_PIN
available_JJ
for_PIN
sale_NN
assets_NN
,_,
exchange_NN
losses_NN
AstraZenecas_NN
equity_NOMZ
in_PIN
the_DT
net_JJ
assets_NN
of_PIN
such_JJ
and_CC
impairments_NOMZ
are_VPRT [PASS]
taken_VBN
to_PIN
the_DT
income_NN
Business_NOMZ
combinations_NOMZ
the_DT
provisions_NN
associates_NN
and_CC
joint_JJ
ventures_NN
,_,
as_IN
shown_VBN [PRIV]
by_PIN
the_DT
statement_NOMZ
._.
All_QUAN
other_JJ
changes_NN
in_PIN
fair_JJ
value_NN
are_VPRT [BEMA]
of_PIN
IFRS_NN
3_CD
have_VPRT [PEAS]
been_VBN [PASS]
applied_VBN
prospectively_RB
most_EMPH
recent_JJ
accounts_NN
available_JJ
,_,
adjusted_JJ
taken_VBN
to_PIN
reserves_NN
._.
On_PIN
disposal_NN
of_PIN
the_DT
related_VBN
from_PIN
1_CD
January_NN
2003_CD
._.
Business_NOMZ
combinations_NOMZ
where_RB
appropriate_JJ
and_CC
including_VBG
goodwill_NN
on_PIN
asset_NN
,_,
the_DT
accumulated_VBN
changes_NN
in_PIN
fair_JJ
value_NN
that_TSUB
occurred_VBD
before_IN
1_CD
January_NN
2003_CD
have_VPRT [PEAS]
acquisitions_NOMZ
made_VBD
since_OSUB
1_CD
January_NN
1998_CD
._.
recorded_VBN [PASTP]
in_PIN
reserves_NN
are_VPRT [PASS]
included_VBN
in_PIN
the_DT
gain_NN
not_XX0
been_VBN [PASS]
restated_VBN
._.
or_CC
loss_NN
recorded_VBN [WZPAST]
in_PIN
the_DT
income_NN
statement_NOMZ
._.
Financial_NN
Statements_NOMZ
89_CD
Employee_NN
benefits_NN
the_DT
accumulated_VBN
actuarial_JJ
gains_NN
and_PHC
losses_NN
in_PIN
respect_NN
of_PIN
employee_NN
defined_VBN
benefit_NN
plans_NN
have_VPRT [PEAS]
been_VBN [PASS]
recognized_VBN [PRIV]
in_PIN
full_JJ
through_PIN
reserves_NN
._.
Cumulative_JJ
exchange_NN
differences_NN
cumulative_JJ
translation_NOMZ
differences_NN
on_PIN
net_JJ
investments_NOMZ
have_VPRT [PEAS]
been_VBN [PASS]
set_VBN
to_TO
zero_VB
at_PIN
1_CD
January_NN
2003_CD
._.
The_DT
following_VBG
optional_JJ
exemptions_NOMZ
from_PIN
full_JJ
retrospective_JJ
application_NOMZ
of_PIN
IFRS_NN
accounting_GER
policies_NN
have_VPRT [PEAS]
not_XX0
been_VBN [PASS]
adopted_VBN
:_:
Fair_NN
value_NN
or_CC
revaluation_NOMZ
an_DT
entity_NOMZ
may_POMD
elect_VB
to_TO
use_VB
fair_JJ
value_NN
or_CC
a_DT
previous_JJ
GAAP_NN
revaluation_NOMZ
at_PIN
the_DT
opening_GER
balance_NN
sheet_NN
date_NN
._.
Compound_NN
financial_JJ
instruments_NOMZ
if_COND
the_DT
compound_NN
financial_JJ
instruments_NOMZ
are_VPRT
no_RB
longer_RB
outstanding_JJ
at_PIN
the_DT
date_NN
of_PIN
transition_NOMZ
,_,
the_DT
entity_NOMZ
is_VPRT [PASS]
not_XX0
required_VBN [SUAV]
to_TO
split_VB
the_DT
instrument_NOMZ
into_PIN
the_DT
separate_JJ
equity_NOMZ
and_PHC
liability_NOMZ
components_NN
._.
In_CONJ
addition_NULL
,_,
the_DT
Group_NN
has_VPRT [PEAS]
chosen_VBN
to_TO
restate_VB
comparative_JJ
information_NOMZ
with_PIN
respect_NN
to_PIN
IAS_NN
32_CD
Financial_NN
Instruments_NOMZ
:_:
Disclosure_NN
and_PHC
Presentation_NOMZ
and_PHC
IAS_NN
39_CD
Financial_NN
Instruments_NOMZ
:_:
Recognition_NOMZ
and_PHC
Measurement_NOMZ
._.
IFRS_NN
2_CD
Sharebased_JJ
Payments_NOMZ
has_VPRT [PEAS]
been_VBN [PASS]
adopted_VBN
with_PIN
full_JJ
retrospective_JJ
application_NOMZ
._.
The_DT
Group_NN
has_VPRT [SPAU] [PEAS]
also_RB
adopted_VBN
the_DT
amendment_NOMZ
to_PIN
IAS_NN
19_CD
Employee_NN
Benefits_NN
early_TIME
,_,
allowing_VBG [SUAV]
actuarial_JJ
gains_NN
or_CC
losses_NN
to_TO
be_VB [PASS]
recognized_VBN [PRIV]
directly_RB
in_PIN
the_DT
consolidated_JJ
statement_NOMZ
of_PIN
income_NN
and_PHC
expense_NN
in_PIN
the_DT
period_NN
in_PIN
which_WDT [PIRE]
they_TPP3
arise_VPRT
._.
Comparative_JJ
information_NOMZ
has_VPRT [PEAS]
been_VBN [PASS]
prepared_VBN
on_PIN
this_DEMO
basis_NN
._.
Accounting_GER
standards_NN
issued_VBN
but_CC
not_XX0
adopted_VBN
IFRS_NN
7_CD
Financial_NN
Instruments_NOMZ
:_:
Disclosures_NN
was_VBD [PASS]
issued_VBN
in_PIN
August_NN
2005_CD
._.
It_PIT
revises_VPRT
and_PHC
enhances_VPRT
previous_JJ
disclosures_NN
required_VBN [SUAV] [WZPAST]
by_PIN
IAS_NN
32_CD
and_CC
IAS_NN
30_CD
Disclosures_NN
in_PIN
the_DT
Financial_NN
Statements_NOMZ
of_PIN
Banks_NN
and_CC
similar_JJ
Financial_NN
Institutions_NOMZ
._.
It_PIT
is_VPRT [BEMA]
effective_PRED
for_PIN
annual_JJ
periods_NN
beginning_VBG [WZPRES]
on_PIN
or_CC
after_IN
1_CD
January_NN
2007_CD
._.
The_DT
adoption_NOMZ
of_PIN
IFRS_NN
7_CD
will_PRMD
have_VB
no_SYNE
impact_NN
upon_PIN
the_DT
results_NN
or_CC
net_JJ
assets_NN
of_PIN
AstraZeneca_NN
._.
Accounting_GER
policies_NN
in_PIN
respect_NN
of_PIN
the_DT
company_NN
information_NOMZ
for_PIN
AstraZeneca_NN
PLC_NN
are_VPRT [PASS]
set_VBN
out_PIN
on_PIN
page_NN
141_CD
._.
These_DEMP
are_VPRT [BEMA]
in_PIN
accordance_NN
with_PIN
UK_NN
GAAP_NN
._.
